S&P 500 7,506.17 ▲ 86.07 (+1.16%) DOW 51,620.91 ▲ 128.36 (+0.25%) NASDAQ 26,536.24 ▲ 514.58 (+1.98%) US Markets Closed â€ĸ 05:54 PM ET

BRKRP

Bruker Corporation

Price Chart
Latest Quote

$425.22

+16.69 (+4.09%)
Current Price
Previous Close $408.53
Open $410.43
Day High $425.22
Day Low $410.43
Volume 475
Fetched: 2026-06-18T21:54:24
Stock Information
Quarterly Dividend / Yield $11.64 / 2.80%
Quarterly Dividend Yield 2.80%
Quarterly Dividend $11.64
Total Debt $1.70B
Cash Equivalents $133.40M
Revenue $3.46B
Net Income $-36.40M
Sector Healthcare
Industry Medical Devices
Exchange NMS
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$65.02B
Sales$3.46B
Income$-36.40M
Book/sh$16.09
Employees11K
Financial Ratios
Quick Ratio0.65
Current Ratio1.55
Debt/Eq68.12
EPS Growth TTM-17.20%
Returns & Margins
ROA2.70%
ROE-0.43%
Gross Margin47.62%
Operating Margin6.18%
Profit Margin-0.34%
Ownership
Institutional Ownership99.04%
Insider & Institutional transactions data not available
Valuation Ratios
P/B26.43
Analyst Data
Recommendationnone
Technical Indicators
SMA20$409.41
SMA50$350.07
RSI46.50
ATR13.6864
Shares Float103.57M
Short Ratio0.06
Volatility1.30
Rel Volume0.03
Performance History
Week+3.33%
Month+30.28%
Quarter+57.32%
6 Months+24.87%
YTD+18.02%
10 Years+76.03%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-18 $425.22 475
2026-06-17 $408.53 1,100
2026-06-16 $416.47 2,000
2026-06-15 $420.40 300
2026-06-12 $401.31 15,900
2026-06-11 $411.50 800
2026-06-10 $410.89 800
2026-06-09 $419.49 0
2026-06-08 $419.49 700
2026-06-05 $421.23 900
2026-06-04 $460.67 101,400
2026-06-03 $463.61 5,000
2026-06-02 $427.94 65,800
2026-06-01 $434.68 67,300
2026-05-29 $436.06 64,200
2026-05-28 $399.45 6,200
2026-05-27 $368.64 300
2026-05-26 $357.64 13,700
2026-05-22 $342.49 0
2026-05-21 $342.49 10,100
2026-05-20 $337.70 13,800
2026-05-19 $326.39 131,700
About Bruker Corporation

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $1,858,800,000 $1,716,900,000 $1,451,200,000 $1,225,000,000
Cost Of Revenue $1,858,800,000 $1,716,900,000 $1,451,200,000 $1,225,000,000
Total Revenue $3,436,500,000 $3,366,400,000 $2,964,500,000 $2,530,700,000
Operating Revenue $3,436,500,000 $3,366,400,000 $2,964,500,000 $2,530,700,000
Expenses
Interest Expense $60,300,000 $47,900,000 $16,400,000 $16,100,000
Total Expenses $3,200,500,000 $2,987,200,000 $2,475,400,000 $2,068,300,000
Other Income Expense $-167,300,000 $-133,700,000 $60,300,000 $-36,500,000
Other Non Operating Income Expenses $-13,100,000 $-9,700,000 $-11,000,000 $-7,200,000
Net Non Operating Interest Income Expense $-46,700,000 $-38,600,000 $-5,200,000 $-12,000,000
Total Other Finance Cost $1,200,000 - $-3,700,000 $-1,300,000
Interest Expense Non Operating $60,300,000 $47,900,000 $16,400,000 $16,100,000
Operating Expense $1,341,700,000 $1,270,300,000 $1,024,200,000 $843,300,000
General And Administrative Expense $946,500,000 $893,800,000 $729,400,000 $607,400,000
Other Operating Expenses - - $10,300,000 $3,800,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-8,600,000 $113,100,000 $427,200,000 $296,600,000
Net Interest Income $-46,700,000 $-38,600,000 $-5,200,000 $-12,000,000
Interest Income $14,800,000 $9,300,000 $7,500,000 $2,800,000
Normalized Income $113,218,000 $211,060,000 $371,300,800 $317,666,700
Net Income From Continuing And Discontinued Operation $-8,600,000 $113,100,000 $427,200,000 $296,600,000
Total Operating Income As Reported $68,200,000 $253,100,000 $436,900,000 $432,700,000
Net Income Common Stockholders $-22,500,000 $113,100,000 $427,200,000 $296,600,000
Net Income $-8,600,000 $113,100,000 $427,200,000 $296,600,000
Net Income Including Noncontrolling Interests $-8,300,000 $113,800,000 $428,500,000 $298,500,000
Net Income Continuous Operations $-8,300,000 $113,800,000 $428,500,000 $298,500,000
Earnings From Equity Interest Net Of Tax $-1,000,000 $-1,700,000 $2,000,000 $1,000,000
Pretax Income $22,000,000 $206,900,000 $544,200,000 $413,900,000
Special Income Charges $-171,700,000 $-147,700,000 $84,600,000 $-23,500,000
Interest Income Non Operating $14,800,000 $9,300,000 $7,500,000 $2,800,000
Operating Income $236,000,000 $379,200,000 $489,100,000 $462,400,000
Gross Profit $1,577,700,000 $1,649,500,000 $1,513,300,000 $1,305,700,000
Other
Tax Effect Of Unusual Items $-32,382,000 $-26,040,000 $15,400,800 $-8,233,300
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $456,800,000 $562,600,000 $604,200,000 $548,000,000
Total Unusual Items $-154,200,000 $-124,000,000 $71,300,000 $-29,300,000
Reconciled Depreciation $220,300,000 $183,800,000 $114,900,000 $88,700,000
EBITDA (Bullshit earnings) $302,600,000 $438,600,000 $675,500,000 $518,700,000
EBIT $82,300,000 $254,800,000 $560,600,000 $430,000,000
Diluted NI Availto Com Stockholders $-22,500,000 $113,100,000 $427,200,000 $296,600,000
Preferred Stock Dividends $13,900,000 - - -
Minority Interests $-300,000 $-700,000 $-1,300,000 $-1,900,000
Tax Provision $29,300,000 $91,400,000 $117,700,000 $116,400,000
Other Special Charges $35,300,000 $44,900,000 - -
Write Off $20,000,000 $24,600,000 $18,200,000 $0
Impairment Of Capital Assets $111,300,000 $2,200,000 $5,700,000 $300,000
Restructuring And Mergern Acquisition $5,100,000 $76,000,000 $-108,500,000 $23,200,000
Gain On Sale Of Security $17,500,000 $23,700,000 $-13,300,000 $-5,800,000
Research And Development $395,200,000 $376,500,000 $294,800,000 $235,900,000
Selling General And Administration $946,500,000 $893,800,000 $729,400,000 $607,400,000
Other Gand A $946,500,000 $893,800,000 $729,400,000 $607,400,000
Salaries And Wages - - $100,000 $1,000,000
Fetched: 2026-06-13
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $9,200,000 $-638,600,000 $464,100,000 $385,300,000
Total Assets $6,241,400,000 $5,806,700,000 $4,249,900,000 $3,611,800,000
Total Non Current Assets $4,028,900,000 $3,753,500,000 $2,085,700,000 $1,498,600,000
Other Non Current Assets $249,300,000 $232,700,000 $184,000,000 $155,100,000
Non Current Deferred Assets $421,700,000 $286,200,000 $297,200,000 $76,800,000
Non Current Deferred Taxes Assets $421,700,000 $286,200,000 $297,200,000 $76,800,000
Goodwill And Other Intangible Assets $2,447,300,000 $2,419,800,000 $913,100,000 $728,500,000
Other Intangible Assets $899,600,000 $912,500,000 $330,500,000 $270,900,000
Current Assets $2,212,500,000 $2,053,200,000 $2,164,200,000 $2,113,200,000
Other Current Assets $24,100,000 $28,900,000 $18,300,000 $12,800,000
Hedging Assets Current $0 $10,700,000 $12,000,000 $14,800,000
Prepaid Assets $59,000,000 $61,200,000 $55,500,000 $43,300,000
Inventory $1,094,600,000 $1,067,800,000 $968,300,000 $800,100,000
Receivables $736,000,000 $701,200,000 $621,800,000 $595,300,000
Other Receivables $116,900,000 $101,200,000 $83,900,000 $60,800,000
Taxes Receivable $74,200,000 $34,500,000 $45,900,000 $61,800,000
Accounts Receivable $544,900,000 $565,500,000 $492,000,000 $472,700,000
Cash Cash Equivalents And Short Term Investments $298,800,000 $183,400,000 $488,300,000 $645,500,000
Cash And Cash Equivalents $298,800,000 $183,400,000 $488,300,000 $645,500,000
Allowance For Doubtful Accounts Receivable - $-6,500,000 $-4,600,000 $-5,300,000
Gross Accounts Receivable - $572,000,000 $496,600,000 $478,000,000
Assets Held For Sale Current - - $0 $1,400,000
Debt
Net Debt $1,570,300,000 $1,910,900,000 $793,200,000 $573,700,000
Total Debt $2,042,900,000 $2,245,300,000 $1,379,600,000 $1,270,400,000
Long Term Debt And Capital Lease Obligation $1,991,100,000 $2,180,700,000 $1,235,100,000 $1,235,300,000
Long Term Debt $1,852,500,000 $2,061,800,000 $1,160,300,000 $1,200,500,000
Current Debt And Capital Lease Obligation $51,800,000 $64,600,000 $144,500,000 $35,100,000
Current Debt $16,600,000 $32,500,000 $121,200,000 $18,700,000
Other Current Borrowings $16,600,000 $32,500,000 $121,200,000 $18,700,000
Liabilities
Total Liabilities Net Minority Interest $3,731,100,000 $3,991,500,000 $2,836,600,000 $2,480,000,000
Total Non Current Liabilities Net Minority Interest $2,451,900,000 $2,710,200,000 $1,634,500,000 $1,565,700,000
Other Non Current Liabilities $239,200,000 $311,000,000 $240,200,000 $120,800,000
Non Current Deferred Liabilities $221,600,000 $218,500,000 $159,200,000 $163,900,000
Non Current Deferred Taxes Liabilities $112,500,000 $118,500,000 $67,700,000 $62,300,000
Current Liabilities $1,279,200,000 $1,281,300,000 $1,202,100,000 $914,300,000
Other Current Liabilities $165,100,000 $33,400,000 $51,800,000 $23,800,000
Current Deferred Liabilities $441,300,000 $438,200,000 $400,000,000 $370,200,000
Payables And Accrued Expenses $441,300,000 $557,300,000 $439,300,000 $349,100,000
Interest Payable $7,100,000 $10,000,000 - -
Payables $324,900,000 $376,600,000 $360,100,000 $282,400,000
Dividends Payable $11,500,000 $0 - -
Total Tax Payable $97,500,000 $142,500,000 $157,400,000 $104,000,000
Income Tax Payable $76,200,000 $119,600,000 $138,700,000 $85,500,000
Accounts Payable $215,900,000 $234,100,000 $202,700,000 $178,400,000
Equity
Common Stock Equity $2,456,500,000 $1,781,200,000 $1,377,200,000 $1,113,800,000
Total Equity Gross Minority Interest $2,510,300,000 $1,815,200,000 $1,413,300,000 $1,131,800,000
Gains Losses Not Affecting Retained Earnings $-79,500,000 $-103,500,000 $6,000,000 $14,800,000
Other Equity Adjustments $-79,500,000 $-103,500,000 $6,000,000 $14,800,000
Retained Earnings $2,361,800,000 $2,406,700,000 $2,323,800,000 $1,926,000,000
Preferred Securities Outside Stock Equity - - - $6,100,000
Other
Treasury Shares Number $30,904,588 $30,778,879 $30,778,879 $28,366,442
Ordinary Shares Number $152,143,041 $151,677,952 $145,164,826 $147,023,144
Share Issued $183,047,629 $182,456,831 $175,943,705 $175,389,586
Tangible Book Value $9,200,000 $-638,600,000 $464,100,000 $385,300,000
Invested Capital $4,325,600,000 $3,875,500,000 $2,658,700,000 $2,333,000,000
Working Capital $933,300,000 $771,900,000 $962,100,000 $1,198,900,000
Capital Lease Obligations $173,800,000 $151,000,000 $98,100,000 $51,200,000
Total Capitalization $4,309,000,000 $3,843,000,000 $2,537,500,000 $2,314,300,000
Minority Interest $53,800,000 $34,000,000 $36,100,000 $18,000,000
Treasury Stock $1,242,200,000 $1,237,200,000 $1,237,200,000 $1,085,000,000
Additional Paid In Capital $1,414,600,000 $713,400,000 $282,900,000 $256,300,000
Capital Stock $1,800,000 $1,800,000 $1,700,000 $1,700,000
Common Stock $1,800,000 $1,800,000 $1,700,000 $1,700,000
Preferred Stock $0 $0 $0 $0
Non Current Deferred Revenue $109,100,000 $100,000,000 $91,500,000 $101,600,000
Long Term Capital Lease Obligation $138,600,000 $118,900,000 $74,800,000 $34,800,000
Current Deferred Revenue $441,300,000 $438,200,000 $400,000,000 $370,200,000
Current Capital Lease Obligation $35,200,000 $32,100,000 $23,300,000 $16,400,000
Pensionand Other Post Retirement Benefit Plans Current $179,700,000 $187,800,000 $166,500,000 $136,100,000
Current Accrued Expenses $116,400,000 $180,700,000 $79,200,000 $66,700,000
Goodwill $1,547,700,000 $1,507,300,000 $582,600,000 $457,600,000
Net PPE $910,600,000 $814,800,000 $691,400,000 $538,200,000
Accumulated Depreciation $-692,000,000 $-559,000,000 $-524,200,000 $-446,700,000
Gross PPE $1,602,600,000 $1,373,800,000 $1,215,600,000 $984,900,000
Other Properties $165,800,000 $145,500,000 $91,700,000 $51,200,000
Machinery Furniture Equipment $749,200,000 $640,100,000 $586,900,000 $462,600,000
Buildings And Improvements $612,000,000 $540,700,000 $498,100,000 $434,500,000
Land And Improvements $75,600,000 $47,500,000 $38,900,000 $36,600,000
Properties $0 $0 $0 $0
Other Inventories $115,900,000 $101,700,000 $98,300,000 $92,300,000
Finished Goods $243,100,000 $228,500,000 $183,900,000 $128,200,000
Work In Process $343,600,000 $348,900,000 $314,900,000 $278,700,000
Raw Materials $392,000,000 $388,700,000 $371,200,000 $300,900,000
Employee Benefits - - $76,600,000 $45,700,000
Non Current Pension And Other Postretirement Benefit Plans - - $76,600,000 $45,700,000
Other Short Term Investments - - - $0
Fetched: 2026-06-13
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $13,900,000 $136,000,000 $243,200,000 $145,200,000
Operating Activities
Operating Cash Flow $134,100,000 $251,300,000 $350,100,000 $274,400,000
Cash Flow From Continuing Operating Activities $134,100,000 $251,300,000 $350,100,000 $274,300,000
Operating Gains Losses $-56,000,000 $-28,100,000 $18,500,000 $-10,100,000
Investing Activities
Capital Expenditure $-120,200,000 $-115,300,000 $-106,900,000 $-129,200,000
Investing Cash Flow $-196,500,000 $-1,757,300,000 $-326,000,000 $-251,600,000
Cash Flow From Continuing Investing Activities $-196,500,000 $-1,757,300,000 $-326,000,000 $-251,600,000
Net Other Investing Changes $4,800,000 $5,900,000 $32,300,000 -
Financing Activities
Repurchase Of Capital Stock $-10,000,000 $0 $-152,300,000 $-263,100,000
Issuance Of Capital Stock $677,600,000 $409,000,000 $9,500,000 $0
Financing Cash Flow $135,100,000 $1,229,800,000 $-193,400,000 $-415,300,000
Cash Flow From Continuing Financing Activities $135,100,000 $1,229,800,000 $-193,400,000 $-415,300,000
Net Other Financing Charges $-8,300,000 $-24,900,000 $300,000 $-14,500,000
Cash Dividends Paid $-32,900,000 $-30,200,000 $-29,400,000 $-29,800,000
Preferred Stock Dividend Paid $-10,100,000 $0 $0 -
Common Stock Dividend Paid $-22,800,000 $-30,200,000 $-29,400,000 $-29,800,000
Net Preferred Stock Issuance $669,700,000 $0 $0 -
Preferred Stock Issuance $669,700,000 $0 $0 -
Net Common Stock Issuance $-2,100,000 $409,000,000 $-142,800,000 $-263,100,000
Common Stock Issuance $7,900,000 $409,000,000 $9,500,000 $0
Other
Repayment Of Debt $-1,245,300,000 $-1,348,100,000 $-23,500,000 $-111,000,000
Issuance Of Debt $754,000,000 $2,224,000,000 $2,000,000 $300,000
Interest Paid Supplemental Data $71,000,000 $54,600,000 $33,700,000 $24,300,000
Income Tax Paid Supplemental Data $222,500,000 $153,900,000 $96,600,000 $147,400,000
End Cash Position $303,100,000 $186,700,000 $491,600,000 $648,700,000
Beginning Cash Position $186,700,000 $491,600,000 $648,700,000 $1,071,700,000
Effect Of Exchange Rate Changes $43,700,000 $-28,700,000 $12,200,000 $-30,500,000
Changes In Cash $72,700,000 $-276,200,000 $-169,300,000 $-392,500,000
Common Stock Payments $-10,000,000 $0 $-152,300,000 $-263,100,000
Net Issuance Payments Of Debt $-491,300,000 $875,900,000 $-21,500,000 $-110,700,000
Net Long Term Debt Issuance $-491,300,000 $875,900,000 $-21,500,000 $-110,700,000
Long Term Debt Payments $-1,245,300,000 $-1,348,100,000 $-23,500,000 $-111,000,000
Long Term Debt Issuance $754,000,000 $2,224,000,000 $2,000,000 $300,000
Net Investment Purchase And Sale $-7,200,000 $-48,300,000 $-24,800,000 $46,000,000
Purchase Of Investment $-7,200,000 $-48,300,000 $-24,800,000 $-60,200,000
Net Business Purchase And Sale $-73,900,000 $-1,599,600,000 $-226,600,000 $-182,300,000
Purchase Of Business $-73,900,000 $-1,599,600,000 $-226,600,000 $-182,300,000
Net Intangibles Purchase And Sale $-29,400,000 $0 $0 -
Purchase Of Intangibles $-29,400,000 $0 $0 -
Net PPE Purchase And Sale $-90,800,000 $-115,300,000 $-106,900,000 $-115,300,000
Purchase Of PPE $-90,800,000 $-115,300,000 $-106,900,000 $-129,200,000
Change In Working Capital $-144,800,000 $-118,800,000 $-87,800,000 $-144,100,000
Change In Other Working Capital $-52,900,000 $-29,300,000 $-28,700,000 $35,200,000
Change In Payables And Accrued Expense $-158,200,000 $20,900,000 $66,800,000 $26,500,000
Change In Accrued Expense $-26,700,000 $15,400,000 $21,900,000 -
Change In Payable $-131,500,000 $5,500,000 $44,900,000 $26,500,000
Change In Account Payable $-37,500,000 $20,800,000 $1,200,000 $33,300,000
Change In Tax Payable $-94,000,000 $-15,300,000 $43,700,000 $-6,800,000
Change In Income Tax Payable $-94,000,000 $-15,300,000 $43,700,000 $-6,800,000
Change In Inventory $12,100,000 $-69,800,000 $-125,000,000 $-137,900,000
Change In Receivables $54,200,000 $-40,600,000 $-900,000 $-67,900,000
Changes In Account Receivables $54,200,000 $-40,600,000 $-900,000 $-67,900,000
Other Non Cash Items $-21,100,000 $50,400,000 $-172,100,000 $26,900,000
Stock Based Compensation $20,200,000 $25,300,000 $30,900,000 $27,700,000
Asset Impairment Charge $228,300,000 $88,700,000 $41,600,000 $1,600,000
Deferred Tax $-104,500,000 $-63,800,000 $-24,400,000 $-14,800,000
Deferred Income Tax $-104,500,000 $-63,800,000 $-24,400,000 $-14,800,000
Depreciation Amortization Depletion $220,300,000 $183,800,000 $114,900,000 $88,700,000
Depreciation And Amortization $220,300,000 $183,800,000 $114,900,000 $88,700,000
Amortization Cash Flow $121,200,000 $99,100,000 $47,100,000 $37,100,000
Amortization Of Intangibles $121,200,000 $99,100,000 $47,100,000 $37,100,000
Depreciation $99,100,000 $84,700,000 $67,800,000 $51,600,000
Net Foreign Currency Exchange Gain Loss $-56,000,000 $-28,100,000 $18,500,000 -
Net Income From Continuing Operations $-8,300,000 $113,800,000 $428,500,000 $298,500,000
Proceeds From Stock Option Exercised - $6,000,000 $9,500,000 $2,800,000
Sale Of Investment - $4,800,000 $21,200,000 $106,200,000
Sale Of PPE - $1,100,000 $11,100,000 $13,900,000
Gain Loss On Sale Of PPE - $4,600,000 $-8,500,000 $-10,100,000
Gain Loss On Investment Securities - - $-6,800,000 -
Net Short Term Debt Issuance - - - $0
Short Term Debt Payments - - - $0
Short Term Debt Issuance - - - $0
Fetched: 2026-06-13